Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heddle

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Transfusion|October 26, 2022
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasmaNa Li, Michelle P Zeller, Andrew W Shih, et al.
Transfusion|April 11, 2012
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshopMorris A Blajchman, Jeffrey L Carson, John W Eikelboom, et al.
Anesthesiology|November 18, 2021
Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney InjuryJanet Adegboye, Suneeti Sapatnekar, Edward J Mascha, et al.
Blood Advances|November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopeniaManraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Transfusion|January 31, 2026
Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes studyS Ning, N Li, Y Liu, et al.
Thrombosis Research|August 4, 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort studyJason B Giles, Jerome Rollin, Kiana L Martinez, et al.
Thrombosis and Haemostasis|January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and RationaleDonald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Blood|January 7, 2012
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopeniaDonald M Arnold, Nancy M Heddle, Julie Carruthers, et al.
Transfusion|October 15, 2017
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN studyMichelle P Zeller, Rebecca Barty, Nancy M Dunbar, et al.
Transfusion Medicine (Oxford, England)|May 21, 2020
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation riskAndrew W Shih, Matthew T S Yan, Allahna L Elahie, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Transfusion|October 26, 2022
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasmaNa Li, Michelle P Zeller, Andrew W Shih, et al.
Transfusion|April 11, 2012
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshopMorris A Blajchman, Jeffrey L Carson, John W Eikelboom, et al.
Anesthesiology|November 18, 2021
Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney InjuryJanet Adegboye, Suneeti Sapatnekar, Edward J Mascha, et al.
Blood Advances|November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopeniaManraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Transfusion|January 31, 2026
Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes studyS Ning, N Li, Y Liu, et al.
Thrombosis Research|August 4, 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort studyJason B Giles, Jerome Rollin, Kiana L Martinez, et al.
Thrombosis and Haemostasis|January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and RationaleDonald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Blood|January 7, 2012
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopeniaDonald M Arnold, Nancy M Heddle, Julie Carruthers, et al.
Transfusion|October 15, 2017
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN studyMichelle P Zeller, Rebecca Barty, Nancy M Dunbar, et al.
Transfusion Medicine (Oxford, England)|May 21, 2020
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation riskAndrew W Shih, Matthew T S Yan, Allahna L Elahie, et al.
Pageof 21